Followers | 834 |
Posts | 119875 |
Boards Moderated | 17 |
Alias Born | 09/05/2002 |
Monday, April 27, 2009 6:38:06 PM
Here's the arithmetic: According to the 2008 10K report (page 42), as of 2/13/09 there were 62.1M fully-diluted shares, including 5.5M options with an average exercise price of $8.49. Adding in the 2.5M shares issued to GSK as part of the IDX899 license gives 64.6M fully-diluted shares as of today.
However, about one third of the 5.5M options outstanding have an exercise price above the level at which the stock can realistically be expected to trade during the next few years. After excluding such options, the fully-diluted share count is approximately 63M; this is the figure I use for valuation purposes.
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM